The Michigan House has passed bipartisan legislation to ban student cell phone use during classroom instruction across all K-12 grades, setting up a potential Senate vote next week that could make the ...

By year-end 2028, submit new drug application evaluating cemsidomide and dexamethasone for potential accelerated approval in fourth line or later. In Q2 2026, initiate the Phase 1b trial of ...

An AdobeStock photo illustrates cell phone usage in a classroom. Kansas Senate leaders from both parties unveiled bipartisan legislation on Tuesday that would ban cell phones in K-12 classrooms. The ...

CTD402, an allogeneic CAR T-cell therapy, is designed for immediate administration and targets relapsed/refractory T-ALL and ...

Vaxcyte Doses First Participants in Phase 3 Study Evaluating Concomitant Administration of VAX-31 and Seasonal Influenza ...

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost management strategies.

Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today announced that the U.S. Food and Drug Administration has granted orphan drug ...

Hydrogen powertrain developer ZeroAvia has finally broken its silence on the sweeping redundancies made by the company in recent weeks that have seen around half of its workforce culled on the back of ...

Seamless Therapeutics entered into a strategic global research collaboration and licensing agreement with Eli Lilly and ...

Political protests are a powerful tool for shaping public opinion, influencing policy and forcing leaders to do the right ...

When making a Dungeons and Dragons character, few decisions are as important as the class. Furthermore, players must consider what level the campaign is reaching, as any given class is going to ...